Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02509689 · ClinicalTrials.gov registry record · NA
Neurofeedback Technology (GZNT) for Persistent Post-Concussive Symptoms in Soldiers
A NA study, sponsored by The Defense and Veterans Brain Injury Center.
- Completed
- Registry status
- NA
- Development phase
- 172
- Enrollment target
NCT02509689: Completed NA study, sponsored by The Defense and Veterans Brain Injury Center.
NCT02509689 is a NA study that has completed, run by The Defense and Veterans Brain Injury Center. The registered enrollment target is 172 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02509689, a NA study, has completed, sponsored by The Defense and Veterans Brain Injury Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 172 participants
- Enrollment target
Study Summary
A new technology called Global Z-Score Neurofeedback Technology (GZNT) has been identified that can overcome an existing barrier to the use of neurofeedback as a treatment technique in a military setting. Neurofeedback, or EEG Biofeedback, is a form of biofeedback that uses the brain's own electrical activity as the training parameter. With sufficient practice, the brain can learn to change its own activity through finely tuned feedback using computerized sounds, graphs and animations. Previous attempts at using neurofeedback as a treatment modality have been subject to a lack of standardization and have required significant expertise on the part of the provider. This new GZNT technology allows neurofeedback to be administered in a standardized and semi-automated fashion, which, if effective, will represent a significant advance toward providing this promising treatment modality to Service Members in a military or VA setting. This study will determine feasibility and preliminary evidence of efficacy for this neurofeedback technology in a pilot study of soldiers with medical issues associated with Traumatic Brain Injury (TBI). GZNT technology has the potential to provide a cost-efficient, non-invasive/non-pharmacological approach to recovery from impact and/or blast-induced brain injury, and holds promise to simultaneously address emotional symptoms that are often a part of the post-concussion symptom picture.
Primary Outcome
EEG measures - Global Z-Score metric for 5 variables in 4 frequency bands - measure std diff within subject and for group
Interventions
- BEHAVIORAL Global Z-Score Neurofeedback Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 172 participants |
| Start Date | 2014-12 |
| Est. Completion | 2022-03 |
| Phase | NA |
What the finished NCT02509689 record still lists
NCT02509689 is an interventional study that assigns participants to a tested intervention. The registered 172 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 1 intervention - of which Global Z-Score Neurofeedback Training is the first listed.
NCT02509689 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02509689 about?
NCT02509689 is a clinical study titled "Neurofeedback Technology (GZNT) for Persistent Post-Concussive Symptoms in Soldiers". A new technology called Global Z-Score Neurofeedback Technology (GZNT) has been identified that can overcome an existing barrier to the use of neurofeedback as a treatment technique in a military setting. Neurofeedback, or EEG Biofeedback, is a form of biofeedback that uses the brain's own electrica...
What is the current status of trial NCT02509689?
This trial is currently completed. It is a NA study. The enrollment target is 172 participants. The study started on 2014-12. Estimated completion is 2022-03.
What interventions are being tested in trial NCT02509689?
The interventions under investigation include: Global Z-Score Neurofeedback Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT02509689?
This trial is sponsored by The Defense and Veterans Brain Injury Center, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02509689's enrollment target sits among peer trials
172 612th of 2000 higher than 1,389 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04801797 · 172 participants · Phase 2
Venetoclax + Azacitidine vs. Induction Chemotherapy in AML
- NCT04867317 · 172 participants · Phase 3
Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)
- NCT05357040 · 172 participants · Phase 2
Antidepressant Effects of Nitrous Oxide
- NCT05587517 · 172 participants · Phase 2
A Clinical Trial of Interventions to Support Family Surrogates of Critically Ill Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia